Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

Inc.

52 posts
UUBS
UBS Sees Prolonged Supply Tightness Supporting Micron Technology, Inc. (MU)
Read More

Here’s What Citi and UBS Think About Micron Technology (MU)

  • 2026-04-22
​Micron Technology, Inc. (NASDAQ:MU) is among the Stocks That Will Double in the Next 5 Years. ​The Street…
UUBS
UBS Heightens Expectations for Corteva (CTVA) with an $8 Price Target Raise
Read More

UBS Heightens Expectations for Corteva (CTVA) with an $8 Price Target Raise

  • 2026-04-21
Corteva, Inc. (NYSE:CTVA) is one of the 10 High Growth Chemical Stocks to Buy. UBS Heightens Expectations for…
UUBS
UBS Maintains Neutral Rating on Automatic Data Processing (ADP)
Read More

UBS Maintains Neutral Rating on Automatic Data Processing (ADP)

  • 2026-04-19
Automatic Data Processing, Inc. (NASDAQ:ADP) is one of the 12 Oversold Blue Chip Stocks to Buy According to Analysts.…
NNovartis
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Read More

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

  • 2026-04-17
Novartis Pharma AG – Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases   – Lead…
UUBS
UBS Raises Merck (MRK) Price Forecast as Part of Sector Preview
Read More

UBS Raises Merck (MRK) Price Forecast as Part of Sector Preview

  • 2026-04-17
Merck & Co., Inc. (NYSE:MRK) is included among the 10 Healthcare Stocks with Highest Dividends. UBS Raises Merck…
NNovartis
Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics
Read More

Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics

  • 2026-04-16
Unnatural Products Inc. Collaboration will harness UNP’s AI enhanced macrocycle platform to drug historically “undruggable” targets SANTA CRUZ, Calif.,…
UUBS
Micron (MU) Banks on a Memory Pricing Upcycle; UBS Just Raised Its Target
Read More

Micron (MU) Banks on a Memory Pricing Upcycle; UBS Just Raised Its Target

  • 2026-04-15
Micron Technology, Inc. (NASDAQ:MU) is one of the must-buy US stocks to buy right now. On April 8,…
UUBS
Chubb Limited (CB) Serves as Lead Underwriter for Strait of Hormuz Shipping Insurance Program
Read More

UBS Raises its Price Target on MetLife (MET) to $102

  • 2026-04-13
MetLife, Inc. (NYSE:MET) is one of the 8 Cheap Large Cap Stocks to Buy Now. On April 9,…
RRoche
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Read More

C4 Therapeutics Expands Long-Term Partnership with Roche

  • 2026-04-09
Agreement Focused on Developing DACs With Payloads For Two Oncology Targets, With an Option for a Third Target…
UUBS
JPMorgan, UBS, and RBC Capital Raise Venture Global (VG) Price Targets
Read More

JPMorgan, UBS, and RBC Capital Raise Venture Global (VG) Price Targets

  • 2026-04-08
Venture Global, Inc. (NYSE:VG) is one of the 10 Best Performing Stocks of Q1 2026 to Watch for…
NNovartis
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
Read More

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

  • 2026-03-27
– Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases     – Lead asset…
UUBS
UBS Raises Casey’s (CASY) Target; Wells Fargo Highlights Strong Q3 Momentum
Read More

UBS Raises Casey’s (CASY) Target; Wells Fargo Highlights Strong Q3 Momentum

  • 2026-03-21
Casey’s General Stores, Inc. (NASDAQ:CASY) is included among the 14 High Growth Dividend Paying Stocks to Invest in…
Switzerland
www.europesays.com